Ermis Menekse, Falcone Natashya, Roberto de Barros Natan, Mecwan Marvin, Haghniaz Reihaneh, Choroomi Auveen, Monirizad Mahsa, Lee Yeji, Song Jihyeon, Cho Hyun-Jong, Zhu Yangzhi, Kang Heemin, Dokmeci Mehmet R, Khademhosseini Ali, Lee Junmin, Kim Han-Jun
Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), Pohang, Gyeongbuk, 37673, Republic of Korea.
Bioact Mater. 2023 Feb 15;25:360-373. doi: 10.1016/j.bioactmat.2023.02.005. eCollection 2023 Jul.
The tumor microenvironment consists of diverse, complex etiological factors. The matrix component of pancreatic ductal adenocarcinoma (PDAC) plays an important role not only in physical properties such as tissue rigidity but also in cancer progression and therapeutic responsiveness. Although significant efforts have been made to model desmoplastic PDAC, existing models could not fully recapitulate the etiology to mimic and understand the progression of PDAC. Here, two major components in desmoplastic pancreatic matrices, hyaluronic acid- and gelatin-based hydrogels, are engineered to provide matrices for tumor spheroids composed of PDAC and cancer-associated fibroblasts (CAF). Shape analysis profiles reveals that incorporating CAF contributes to a more compact tissue formation. Higher expression levels of markers associated with proliferation, epithelial to mesenchymal transition, mechanotransduction, and progression are observed for cancer-CAF spheroids cultured in hyper desmoplastic matrix-mimicking hydrogels, while the trend can be observed when those are cultured in desmoplastic matrix-mimicking hydrogels with the presence of transforming growth factor-β1 (TGF-β1). The proposed multicellular pancreatic tumor model, in combination with proper mechanical properties and TGF-β1 supplement, makes strides in developing advanced pancreatic models for resembling and monitoring the progression of pancreatic tumors, which could be potentially applicable for realizing personalized medicine and drug testing applications.
肿瘤微环境由多种复杂的病因因素组成。胰腺导管腺癌(PDAC)的基质成分不仅在诸如组织硬度等物理特性方面发挥重要作用,而且在癌症进展和治疗反应性方面也发挥重要作用。尽管已经做出了巨大努力来构建促结缔组织增生性PDAC模型,但现有的模型仍无法完全重现病因,以模拟和理解PDAC的进展。在此,对促结缔组织增生性胰腺基质中的两种主要成分,即基于透明质酸和明胶的水凝胶进行工程改造,以为由PDAC和癌症相关成纤维细胞(CAF)组成的肿瘤球体提供基质。形状分析轮廓显示,加入CAF有助于形成更致密的组织。在模拟高促结缔组织增生性基质的水凝胶中培养的癌症-CAF球体,观察到与增殖、上皮-间质转化、机械转导和进展相关的标志物表达水平更高,而当在存在转化生长因子-β1(TGF-β1)的模拟促结缔组织增生性基质的水凝胶中培养这些球体时,也能观察到这种趋势。所提出的多细胞胰腺肿瘤模型,结合适当的力学性能和TGF-β1补充,在开发用于模拟和监测胰腺肿瘤进展的先进胰腺模型方面取得了进展,这可能潜在地适用于实现个性化医学和药物测试应用。